{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T07:28:27Z","timestamp":1688542107406},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s10354-016-0439-0","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T13:07:27Z","timestamp":1453900047000},"page":"139-142","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Metabolische und reproduktionsmedizinische Aspekte des Polyzystischen Ovarsyndroms (PCOS)"],"prefix":"10.1007","volume":"166","author":[{"given":"Michael","family":"Feichtinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Stopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Go\u0308bl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,27]]},"reference":[{"key":"439_CR1","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2010","unstructured":"March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reprod. 2010;25:544\u201351.","journal-title":"Human Reprod"},{"key":"439_CR2","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/des232","volume":"27","author":"BO Yildiz","year":"2012","unstructured":"Yildiz BO, Bozdag G, Yapici Z, et al. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27:3067\u201373.","journal-title":"Hum Reprod"},{"key":"439_CR3","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.fertnstert.2010.09.032","volume":"95","author":"R Azziz","year":"2011","unstructured":"Azziz R, Dumesic DA, Goodarzi MO. Polycystic ovary syndrome: an ancient disorder? Fertil Steril. 2011;95:1544\u20138.","journal-title":"Fertil Steril"},{"key":"439_CR4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7:219\u201331.","journal-title":"Nat Rev Endocrinol"},{"key":"439_CR5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam EA-","year":"2004","unstructured":"Rotterdam EA-SPcwg. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41\u20137.","journal-title":"Hum Reprod"},{"key":"439_CR6","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237\u201345.","journal-title":"J Clin Endocrinol Metab"},{"key":"439_CR7","doi-asserted-by":"crossref","first-page":"299 e1","DOI":"10.1016\/j.ajog.2012.07.023","volume":"207","author":"EM Okoroh","year":"2012","unstructured":"Okoroh EM, Hooper WC, Atrash HK, et al. Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003\u20132008. Am J Obstet Gynecol. 2012;207:299 e1\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"439_CR8","doi-asserted-by":"crossref","first-page":"ITC-2","DOI":"10.7326\/0003-4819-154-3-201102010-01002","volume":"154","author":"JF Wilson","year":"2011","unstructured":"Wilson JF. In the clinic. The polycystic ovary syndrome. Ann Intern Med. 2011;154:ITC-2\u2013ITC-15. (quiz ITC2\u20136).","journal-title":"Ann Intern Med"},{"key":"439_CR9","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/humrep\/16.9.1995","volume":"16","author":"RJ Norman","year":"2001","unstructured":"Norman RJ, Masters L, Milner CR, et al. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod. 2001;16:1995\u20138.","journal-title":"Hum Reprod"},{"key":"439_CR10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","volume":"16","author":"LJ Moran","year":"2010","unstructured":"Moran LJ, Misso ML, Wild RA, et al. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16:347\u201363.","journal-title":"Hum Reprod Update"},{"key":"439_CR11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.fertnstert.2004.01.041","volume":"82","author":"E Carmina","year":"2004","unstructured":"Carmina E, Lobo RA. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril. 2004;82:661\u20135.","journal-title":"Fertil Steril"},{"key":"439_CR12","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","volume":"83","author":"CM DeUgarte","year":"2005","unstructured":"DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril. 2005;83:1454\u201360.","journal-title":"Fertil Steril"},{"key":"439_CR13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11892-006-0056-1","volume":"6","author":"MY Boudreaux","year":"2006","unstructured":"Boudreaux MY, Talbott EO, Kip KE, et al. Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up. Curr Diab Rep. 2006;6:77\u201383.","journal-title":"Curr Diab Rep"},{"key":"439_CR14","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","volume":"90","author":"T Apridonidze","year":"2005","unstructured":"Apridonidze T, Essah PA, Iuorno MJ, et al. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:1929\u201335.","journal-title":"J Clin Endocrinol Metab"},{"key":"439_CR15","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3109\/09513590.2010.508852","volume":"27","author":"MP Rocha","year":"2011","unstructured":"Rocha MP, Marcondes JA, Barcellos CR, et al. Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors. Gynecol Endocrinol. 2011;27:814\u20139.","journal-title":"Gynecol Endocrinol"},{"key":"439_CR16","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","volume":"89","author":"EO Talbott","year":"2004","unstructured":"Talbott EO, Zborowski JV, Rager JR, et al. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89:5454\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"439_CR17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/edrv-17-2-121","volume":"17","author":"A Gougeon","year":"1996","unstructured":"Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev. 1996;17:121\u201355.","journal-title":"Endocr Rev"},{"key":"439_CR18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0015-0282(98)00141-1","volume":"70","author":"R Azziz","year":"1998","unstructured":"Azziz R, Waggoner WT, Ochoa T, et al. Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. Fertil Steril. 1998;70:274\u20138.","journal-title":"Fertil Steril"},{"key":"439_CR19","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1093\/humrep\/14.10.2544","volume":"14","author":"RD Schramm","year":"1999","unstructured":"Schramm RD, Bavister BD. A macaque model for studying mechanisms controlling oocyte development and maturation in human and non-human primates. Hum Reprod. 1999;14:2544\u201355.","journal-title":"Hum Reprod"},{"key":"439_CR20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF02765826","volume":"14","author":"F Cano","year":"1997","unstructured":"Cano F, Garcia-Velasco JA, Millet A, et al. Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women. J Assist Reprod Genet. 1997;14:254\u201361.","journal-title":"J Assist Reprod Genet"},{"key":"439_CR21","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1210\/jc.2006-1123","volume":"92","author":"L Tian","year":"2007","unstructured":"Tian L, Shen H, Lu Q, et al. Insulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatment. J Clin Endocrinol Metab. 2007;92:1430\u20133.","journal-title":"J Clin Endocrinol Metab"},{"key":"439_CR22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","volume":"12","author":"CM Boomsma","year":"2006","unstructured":"Boomsma CM, Eijkemans MJ, Hughes EG, et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12:673\u201383.","journal-title":"Hum Reprod Update"},{"issue":"19","key":"439_CR23","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","volume":"358","author":"BE Metzger","year":"2008","unstructured":"HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991\u20132002.","journal-title":"N Engl J Med"},{"key":"439_CR24","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.2337\/dc15-S015","volume":"38","author":"American Diabetes Association","year":"2015","unstructured":"American Diabetes Association. (12) management of diabetes in pregnancy. Diabetes Care. 2015;38 Suppl:S77\u20139.","journal-title":"Diabetes Care"},{"key":"439_CR25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/humrep\/15.1.24","volume":"15","author":"MW Elting","year":"2000","unstructured":"Elting MW, Korsen TJ, Rekers-Mombarg LT, et al. Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum Reprod. 2000;15:24\u20138.","journal-title":"Hum Reprod"},{"key":"439_CR26","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1530\/eje.0.1450749","volume":"145","author":"H Bili","year":"2001","unstructured":"Bili H, Laven J, Imani B, et al. Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years. Eur J Endocrinol. 2001;145:749\u201355.","journal-title":"Eur J Endocrinol"},{"key":"439_CR27","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.fertnstert.2011.11.041","volume":"97","author":"D Panidis","year":"2012","unstructured":"Panidis D, Tziomalos K, Macut D, et al. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome. Fertil Steril. 2012;97:494\u2013500.","journal-title":"Fertil Steril"},{"key":"439_CR28","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.steroids.2013.04.004","volume":"78","author":"DA Dumesic","year":"2013","unstructured":"Dumesic DA, Lobo RA. Cancer risk and PCOS. Steroids. 2013;78:782\u20135.","journal-title":"Steroids"},{"key":"439_CR29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","volume":"75","author":"MD Kahsar-Miller","year":"2001","unstructured":"Kahsar-Miller MD, Nixon C, Boots LR, et al. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril. 2001;75:53\u20138.","journal-title":"Fertil Steril"},{"key":"439_CR30","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1210\/jcem.87.5.8387","volume":"87","author":"RS Legro","year":"2002","unstructured":"Legro RS, Kunselman AR, Demers L, et al. Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87:2134\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"439_CR31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2265.2004.01981.x","volume":"60","author":"R Kaushal","year":"2004","unstructured":"Kaushal R, Parchure N, Bano G, et al. Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries. Clin Endocrinol (Oxf). 2004;60:322\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"439_CR32","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1210\/jc.2009-1333","volume":"94","author":"AD Coviello","year":"2009","unstructured":"Coviello AD, Sam S, Legro RS, et al. High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity. J Clin Endocrinol Metab. 2009;94:4361\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"439_CR33","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1210\/jc.2007-2256","volume":"93","author":"SE Recabarren","year":"2008","unstructured":"Recabarren SE, Smith R, Rios R, et al. Metabolic profile in sons of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93:1820\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"439_CR34","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1093\/humrep\/der101","volume":"26","author":"MC Taylor","year":"2011","unstructured":"Taylor MC, Reema Kar A, Kunselman AR, et al. Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome. Hum Reprod. 2011;26:2226\u201331.","journal-title":"Hum Reprod"},{"key":"439_CR35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1139\/h06-007","volume":"31","author":"B Bruner","year":"2006","unstructured":"Bruner B, Chad K, Chizen D. Effects of exercise and nutritional counseling in women with polycystic ovary syndrome. Appl Physiol Nutr Metab. 2006;31:384\u201391.","journal-title":"Appl Physiol Nutr Metab"},{"key":"439_CR36","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/humrep\/deg440","volume":"18","author":"E Carmina","year":"2003","unstructured":"Carmina E, Legro RS, Stamets K, et al. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod. 2003;18:2289\u201393.","journal-title":"Hum Reprod"},{"key":"439_CR37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMct0707092","volume":"358","author":"JE Nestler","year":"2008","unstructured":"Nestler JE. Metformin for the treatment of the polycystic ovary syndrome. N Engl J Med. 2008;358:47\u201354.","journal-title":"N Engl J Med"},{"key":"439_CR38","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2337\/diacare.20.2.188","volume":"20","author":"T Antonucci","year":"1997","unstructured":"Antonucci T, Whitcomb R, McLain R, et al. Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone. Diabetes Care. 1997;20:188\u201393.","journal-title":"Diabetes Care"},{"key":"439_CR39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2265.2008.03369.x","volume":"70","author":"S Palomba","year":"2009","unstructured":"Palomba S, Pasquali R, Orio F, et al. Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis. Clin Endocrinol (Oxf). 2009;70:311\u201321.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"439_CR40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1313517","volume":"371","author":"RS Legro","year":"2014","unstructured":"Legro RS, Brzyski RG, Diamond MP, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014;371:119\u201329.","journal-title":"N Engl J Med"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-016-0439-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-016-0439-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-016-0439-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T19:07:58Z","timestamp":1553627278000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-016-0439-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,27]]},"references-count":40,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["439"],"URL":"https:\/\/doi.org\/10.1007\/s10354-016-0439-0","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,27]]}}}